We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > adjuvant

News List

NICE recommends monotherapy for adjuvant treatment of stage 3 melanoma pharmatimes
December 17, 2021
The approval follows a successful period of monitoring and patient access through the Cancer Drugs Fund.
Adjuvant RT May Cut Recurrence in Some With Prostate Cancer drugs
August 13, 2019
Adjuvant radiotherapy after radical prostatectomy compared with surgery alone may prolong biochemical recurrence-free survival in patients with locally advanced prostate cancer...
NICE rejects adjuvant use of Perjeta post-surgery pharmatimes
June 21, 2018
The National Institute for Health and Care Excellence says adjuvant use of Roche’s breast cancer drug Perjeta in patients who have had surgery is not cost effective for the NHS.